Abiopharma

(10% Negative) CARTESIAN THERAPEUTICS, INC. (RNAC) Announces Delay in provided Development Timeline Due to Geopolitical Situation, Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Cellectar Biosciences to Highlight Strategic Initiatives for 2026 at Upcoming Biotech Showcase during 44th Annual JP Morgan Healthcare Conference

Aptevo Therapeutics Secures $60 Million Equity Line of Credit to Support Multispecific Portfolio Advancement, Increase Strategic Optionality

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results

Cartesian Therapeutics Highlights Recent Progress and Outlines 2026 Outlook

Curis Announces Closing of Private Placement Totaling up to $80.8 Million in Gross Proceeds

Encompass Health Corporation - Encompass Health announces date of 2025 fourth quarter earnings call

(90% Positive) Savara Inc (SVRA) Files Form 8-K

(30% Negative) NewAmsterdam Pharma Company N.V. (NAMS) Announces Clinical Trial Timeline Adjustment

Revvity - Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models

The Oncology Institute Announces Leadership Promotions

Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models

Encompass Health announces date of 2025 fourth quarter earnings call

New Form 3 - Zoetis Inc. Filed: 2026-01-09 AccNo: 0001628280-26-001452 Size: 395 KB